Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
21/05 | Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding | CI |
2015 | Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release | CI |
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - |
Company contact information
Manzo Pharmaceuticals, Inc.
6153 Main Street Suite 2
L4A 3R6, Stouffville
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.1T | |
+20.02% | 8.29TCr | |
+13.33% | 915.28Cr | |
+48.35% | 465.47Cr | |
-20.52% | 457.72Cr | |
+7.99% | 407.35Cr | |
+8.44% | 223.97Cr | |
-25.72% | 221.33Cr | |
+12.16% | 203.41Cr | |
-41.98% | 181.7Cr |
- Stock Market
- Equities
- MNZO Stock
- Company Manzo Pharmaceuticals, Inc.